SB 438 prevents health insurance companies and health plans in Oklahoma from requiring providers (like doctors, hospitals, or clinics) to accept only credit card payments for services. It mandates that insurers must notify providers about any fees tied to payment methods and provide clear instructions for choosing alternatives like electronic transfers. The bill also prohibits charging fees for standard electronic payments (ACH) without provider consent and voids any contract clauses that try to bypass these rules. These changes directly affect health insurers, health plans, and healthcare providers across Oklahoma, taking effect November 1, 2025.
HB 1585 establishes mandatory training requirements for pharmacy technicians in Oklahoma. It requires pharmacy technicians to complete two phases of training: Phase I before receiving a permit, and Phase II within 90 days of permit issuance. Pharmacy managers must develop, document, and verify all training, with failure to complete Phase II voiding the permit. The law directly affects pharmacy technicians seeking permits, their employers (pharmacy managers), and the Oklahoma Pharmacy Board, which oversees compliance. The bill takes effect November 1, 2025.
HB 1201 creates a 70% tax credit for Oklahoma taxpayers who donate to certified pregnancy resource centers, capping the credit at $50,000 per donor annually. To qualify, centers must provide free, non-abortion services (like prenatal care and counseling) without performing or referring for abortions, and must be certified by the state health director. The total annual tax credits for all donors are capped at $5 million, with annual adjustments to prevent exceeding this limit. The credit applies to donations of $100 or more and takes effect January 1, 2026.
HB 1380 creates Oklahoma's Insulin Access and Affordability Program within the State Department of Health to lower insulin costs and improve access. The program requires the state to partner with nonprofit pharmaceutical companies and organizations to secure fast-acting insulin at capped prices: $30 per vial or $55 per pack of five pre-filled pens, with agreements detailing projected savings for Oklahoma residents and self-insured plans. It directly affects Oklahomans using insulin, particularly those on public or private insurance, by aiming to reduce out-of-pocket costs through competitive pricing. The program takes effect July 1, 2025, and requires nonprofits to commit to specific price points and savings reporting.
HB 2012 removes the July 1, 2026, expiration date for Oklahoma's harm-reduction services program, making it permanent. It authorizes government agencies, religious institutions, nonprofits, for-profit companies, and tribal governments to provide services including needle distribution, HIV/hepatitis testing, referrals for addiction treatment, and safe needle disposal. Providers must register with the State Department of Health and report quarterly on services delivered, such as the number of people served, needles distributed, and test results. This bill directly affects people who use injection drugs by expanding access to health services aimed at reducing disease transmission and overdose risks.
HB 1686 requires hospitals to establish evidence-based sepsis protocols for early identification and treatment of patients with sepsis or septic shock, including staff training and population-specific guidelines (e.g., for pediatric or adult patients). It also mandates that Medicaid payors and health insurance plans (including private insurers) use specific clinical criteria for sepsis billing: a provider’s diagnosis of sepsis plus two symptoms of inflammatory response (such as fever, rapid heartbeat, or abnormal white blood cell count). The bill directly affects hospitals providing care and insurance companies administering Medicaid or health benefit plans in Oklahoma. It becomes effective November 1, 2025, aligning with federal coding standards for sepsis diagnosis.
SB 808 clarifies Oklahoma's physical therapy referral rules, allowing licensed physical therapists (and assistants under supervision) to evaluate and treat patients without a doctor's referral for up to 30 days, except for workers' compensation cases. It specifically exempts children receiving physical therapy under federal special education laws (IDEA/504), screening/education services, and non-injury-related fitness/wellness programs. The bill explicitly states physical therapists cannot practice "healing arts" beyond their scope and maintains existing restrictions on non-therapeutic services. Signed into law on April 23, 2025, it takes effect November 1, 2025.
HB 2802 amends Oklahoma's licensing laws for professions and occupations to limit when criminal history can block a license. It prohibits denial based on sealed/expunged records, arrests without conviction, or convictions over five years old (unless involving specific violent offenses like domestic abuse or sex offenses). Licensing agencies must now consider factors like the offense's relevance to the job, time passed, rehabilitation efforts, and provide written notice with appeal rights if denying a license. This directly affects applicants with criminal records seeking licenses for jobs like nursing, contracting, or childcare, ensuring decisions are based on specific, relevant criteria rather than vague standards.
HB 1853 requires health insurance plans covering children to provide full, cost-sharing-free coverage for all recommended childhood immunizations (including those mandated by the State Board of Health) from birth through age 18. It also allows policyholders to pay for health care services directly at a negotiated lower rate and submit documentation to have that payment count toward their deductible. The law applies to most health insurance plans (excluding dental, vision, short-term coverage, and others listed in the bill) and takes effect November 1, 2025. This ensures children's routine vaccines are fully covered without out-of-pocket costs for families.
This bill requires Oklahoma's Medicaid program to approve prior authorization for atypical antipsychotic drugs not on the preferred drug list when treating mood disorders like schizophrenia, bipolar disorder, or related conditions. It mandates approval if a patient has failed a trial of a preferred drug in the past year or is stable on a non-preferred medication. The policy ensures these drugs are covered at parity with other branded medications in the same class, without additional restrictions beyond standard Medicaid criteria.
